Biosynex SA
PAR:ALBIO

Watchlist Manager
Biosynex SA Logo
Biosynex SA
PAR:ALBIO
Watchlist
Price: 0.495 EUR 1.85%
Market Cap: 9.3m EUR
Section:
 

Relative Value

The Relative Value of one ALBIO stock under the Base Case scenario is 4.163 EUR. Compared to the current market price of 0.495 EUR, Biosynex SA is Undervalued by 88%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALBIO Relative Value
Base Case
4.163 EUR
Undervaluation 88%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.1
P/S
P/S
Price to Sales
0.1
vs History
98
vs Industry
85
Median 3Y
0.4
Median 5Y
0.4
Industry
2.3
Forward
0.1
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
45
Median 3Y
-0.4
Median 5Y
1.2
Industry
22.5
Forward
1
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
26
Median 3Y
-2.7
Median 5Y
-2
Industry
14.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-1.4
Median 5Y
-1.1
Industry
21.5
More Details
0.2
P/B
P/B
Price to Book Value
0.2
vs History
92
vs Industry
81
Median 3Y
0.5
Median 5Y
0.7
Industry
2.2
More Details
0.1
EV/S
EV/S
Enterprise Value to Sales
0.1
vs History
85
vs Industry
86
Median 3Y
0.3
Median 5Y
0.3
Industry
2.6
Forward
0.1
More Details
0.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
0.2
vs History
77
vs Industry
73
Median 3Y
0.4
Median 5Y
0.4
Industry
5.2
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
56
Median 3Y
-1.4
Median 5Y
0.3
Industry
11.9
Forward
0.9
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
50
Median 3Y
-0.7
Median 5Y
0.1
Industry
16.9
Forward
2.2
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
36
Median 3Y
-2.9
Median 5Y
-2.6
Industry
14.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-1.6
Median 5Y
-1.5
Industry
18.7
More Details
0.1
EV/IC
EV/IC
Enterprise Value to IC
0.1
vs History
98
vs Industry
86
Median 3Y
0.2
Median 5Y
0.3
Industry
1.9
More Details

Multiples Across Competitors

ALBIO Competitors Multiples
Biosynex SA Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
FR
Biosynex SA
PAR:ALBIO
9.1m EUR 0.1 -0.1 -2.4 -0.2
US
Abbott Laboratories
NYSE:ABT
210.8B USD 4.8 15.1 19.3 26.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
200.1B USD 20.8 72.8 55.8 68.1
US
Boston Scientific Corp
NYSE:BSX
137.2B USD 7.1 49.1 28.8 39.2
US
Stryker Corp
NYSE:SYK
133.5B USD 5.5 45.4 22.2 26.9
IE
Medtronic PLC
NYSE:MDT
127.7B USD 3.7 26.8 15.1 21.8
DE
Siemens Healthineers AG
XETRA:SHL
48.5B EUR 2.1 22.5 12.8 18.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
55.9B USD 13.4 54.4 39.1 43.3
US
Becton Dickinson and Co
NYSE:BDX
53.9B USD 2.5 32.1 12 20.4
US
Edwards Lifesciences Corp
NYSE:EW
48.4B USD 8.2 35.4 25.2 27.7
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
37.8B USD 1.9 17.1 12.7 15.4
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
FR
Biosynex SA
PAR:ALBIO
Average EV/EBITDA: 24.3
Negative Multiple: -2.4 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
19.3
12%
1.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
55.8
26%
2.1
US
Boston Scientific Corp
NYSE:BSX
28.8
22%
1.3
US
Stryker Corp
NYSE:SYK
22.2
13%
1.7
IE
Medtronic PLC
NYSE:MDT
15.1
8%
1.9
DE
Siemens Healthineers AG
XETRA:SHL
12.8
11%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.1
14%
2.8
US
Becton Dickinson and Co
NYSE:BDX
12
9%
1.3
US
Edwards Lifesciences Corp
NYSE:EW
25.2
13%
1.9
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
12.7
10%
1.3

See Also

Summary
ALBIO intrinsic value, competitors valuation, and company profile.
DCF Valuation
ALBIO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
ALBIO stock valuation using valuation multiples.
Wall Street Estimates
ALBIO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
ALBIO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 302,000+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.